Primary Care - North Greece Internal Medicine & Pediatrics

-
Image
prevnar 13 for adults over 50 :: Article Creator Pfizer Continuing Talks With CDC About Recommending Prevnar In Adults Over 50 Pfizer issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices regarding the use of Prevnar 13 in adults 50 years of age and older: "Pfizer believes Prevnar 13 should be recommended for all adults 50 years of age and older given the current burden of pneumococcal disease in this age group...We are committed to continuing discussions with the CDC about a recommendation concerning the use of Prevnar 13 in adults 50 years of age and older...We are confident that Prevnar 13 has the potential to help address the burden of life-threatening pneumococcal pneumonia and invasive disease in adults 50 years of age and older, while offering a compelling value proposition for the United States health care system...Therefo...
Post a Comment

CDC Panel Votes to Recommend Shingrix for Immunocompromised Adults - Monthly Prescribing Reference

-

The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of herpes zoster (shingles) and its complications in adults 19 years of age and older who are, or will be immunodeficient or immunosuppressed due to disease or therapy.

Shingrix is intended for intramuscular injection in 2 doses separated by 2 to 6 months in immunocompetent adults. In adults who are or will be immunodeficient or immunosuppressed due to known disease or therapy and who would benefit from a shorter vaccination schedule, the second dose may be administered 1 to 2 months after the first dose.

The recommendation was based on data from clinical studies that assessed the efficacy and safety of Shingrix in adults 18 years of age and older who previously had an autologous hematopoietic stem cell transplant (auHSCT; N=1721) and in those undergoing treatment for hematologic malignancies (N=515; post-hoc analysis).

Shingrix was found to be 68.2% (95% CI, 55.5-77.6) effective against the development of herpes zoster in immunocompromised adults who received an auHSCT 50 to 70 days prior to the first dose and who were expected to receive prophylactic antiviral therapy for at most 6 months post-transplant. In the hematologic malignancy study, post hoc analysis showed Shingrix was 87.2% (95% CI, 44.2-98.6) effective against herpes zoster development.

The approval was further supported by safety and immunogenicity data in adults who were, or were anticipated to be immunodeficient or immunosuppressed due to known disease or therapy, including patients with HIV, solid tumors, and renal transplants.

The recommendations will be reviewed for approval by the director of the CDC and the US Department of Health and Human Services. Following approval, the final recommendations will be published in a future Morbidity and Mortality Weekly Report (MMWR).

"Today's recommendation is an important clinical advancement in providing protection from shingles and its complications to adults with immunodeficiency or immunosuppression," said Sabine Luik, Chief Medical Officer & SVP Global Medical Regulatory & Quality, GSK. "The ACIP's vote helps to address an existing unmet need as individuals who are immunocompromised are at an increased risk of the disease."

Shingrix is currently approved for the prevention of herpes zoster in adults 50 years of age and older. It is also approved for the prevention of herpes zoster in adults 18 years of age and older who are or who will be at increased risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy.

Reference

US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up. News release. GlaxoSmithKline. October 20, 2021. Accessed October 21, 2021. https://www.gsk.com/en-gb/media/press-releases/votes-unanimously-to-recommend-shingrix-for-immunocompromised-adults-aged-19-and-up/. 

Topics:

Herpes Zoster Virus Immunization Infectious Disease Vaccines Viral Infections

Comments

Post a Comment

Popular posts from this blog

These Are the Top Doctors in the Hudson Valley in 2022

-
Image
advanced primary care of the ozarks :: Article Creator Integrating Rx With Advanced Primary Care Will Unlock Better Health America's healthcare industry has been squeezed tightly over the past few years with post-pandemic fallout, a declining economy and high consumer expectations. Retail pharmacies are no exception, and it's clear that the traditional pharmacy model is in crisis. With rising costs for medications and supplies and changing consumer retail habits, this doesn't bode well for the brick-and-mortar community pharmacy. Simply put: the traditional pharmacy model is unsustainable. We will soon see a rash of closing retail pharmacies and consumers scrambling to fill needed prescriptions affordably. You might be asking yourself why this should matter to you as HR and benefit professionals. I serve as chief human resources officer for a company that works with many large employers concerned about healthcare costs and the de...
Read more

William Buoni, MD - Wexner Medical Center

-
Image
podiatry billing company :: Article Creator The Best Medical Billing Services Of 2024 1. Get a full picture of the company's features. Claim scrubbing and follow-up are par for the course. You'll also commonly find that RCM companies include reporting, consultation, and EMR and PMS access with your services. Check for these features as you speak with company representatives. You should also determine whether the features that accompany your medical billing leave the company or your own team responsible for entering and coding charges. It's worth asking if your billing service candidates are following the most recent ICD-10 coding system updates. You should also get a sense of the billing company's experience with other practices in your specialty. Lastly, ask about the depth and extent of reporting and analytics solutions. "You'll want to ensure that your medical billing service has implemented & maintains timely bill...
Read more

Who are the top doctors in Columbus? Search by specialty with Columbus Monthly's 2021 list

-
Image
women's preventive services :: Article Creator Women - Search News Team USA wins women's 4x400 for eighth consecutive Olympic gold medal The U.S. Women's have dominated the 4x400 relay, winning eight golds in a row in the event. When Team USA won it in Tokyo it gave the legendary Allyson Felix her 11th Olympic medal, making her the most decorated track and field athlete of all time.
Read more